New York State Common Retirement Fund’s Eledon Pharmaceuticals ELDN Stock Holding History

New York State Common Retirement Fund’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.5K	Hold	4,200	–	–	﹤0.01%	3135
2026 Q1	$12.9K	Hold	4,200	–	–	﹤0.01%	3057
2025 Q4	$6.34K	Hold	4,200	–	–	﹤0.01%	3157
2025 Q3	$10.9K	Sell	4,200 -32,200	-88%	-$94.1K	﹤0.01%	3152
2025 Q2	$98.6K	Buy	+36,400	New	+$109K	﹤0.01%	2672
2017 Q2	–	Sell	-53	Closed	-$7K	–	3195
2017 Q1	$7K	Hold	53	–	–	﹤0.01%	3132
2016 Q4	$8K	Hold	53	–	–	﹤0.01%	3114
2016 Q3	$13K	Hold	53	–	–	﹤0.01%	3123
2016 Q2	$47K	Hold	53	–	–	﹤0.01%	3092
2016 Q1	$48K	Hold	53	–	–	﹤0.01%	3069
2015 Q4	$75K	Hold	53	–	–	﹤0.01%	3067
2015 Q3	$89K	Hold	53	–	–	﹤0.01%	3050
2015 Q2	$114K	Buy	+53	New	+$103K	﹤0.01%	3081

Other funds holding ELDN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

PAM

Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $137M AUM

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

PNFS

PW Nova Financial Services Newtown, Pennsylvania $466M AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MIM

Marco Investment Management Atlanta, Georgia $1.52B AUM 47.33% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

New York State Common Retirement Fund's ELDN Position: Q2 2026 in Review

New York State Common Retirement Fund held its Eledon Pharmaceuticals (ELDN) position steady in Q2 2026 at 4,200 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3135.

New York State Common Retirement Fund first reported a position in ELDN in Q2 2015 and has held it in 13 quarters since. The position peaked at $114K in Q2 2015. 42 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

New York State Common Retirement Fund held 4,200 shares of Eledon Pharmaceuticals worth $16.5K as of Q2 2026.
New York State Common Retirement Fund left its Eledon Pharmaceuticals share count unchanged in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3135 holding.
New York State Common Retirement Fund first reported a position in Eledon Pharmaceuticals in Q2 2015 and has held it in 13 quarters since.
New York State Common Retirement Fund's Eledon Pharmaceuticals position peaked at $114K in Q2 2015.
42 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.